Nura Bio kicks off Phase 1 clinical trials for SARM1 inhibitor NB-4746

Nura Bio, a leading biopharmaceutical company specializing in neuroprotective, small molecule therapies, announced today the initiation of Phase 1 clinical trials for its groundbreaking SARM1 ... Read More